Last update 11 Dec 2024

Liraglutide Biosimilar (Tonghua Dongbao)

Overview

Basic Info

Drug Type
Recombinant polypeptide, Biosimilar
Synonyms
统博力
Target
GLP-1R
Mechanism
GLP-1R agonists(Glucagon-like peptide 1 receptor agonists)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
Diabetes Mellitus, Type 2
Inactive Indication-
Originator Organization
Tonghua Dongbao Pharmaceutical Co., Ltd.Tonghua Dongbao Pharmaceutical Co., Ltd.
Active Organization
Tonghua Dongbao Pharmaceutical Co., Ltd.Tonghua Dongbao Pharmaceutical Co., Ltd.
Inactive Organization
Tonghua Tongbo Biomedical Co., Ltd.
Drug Highest PhaseApproved
First Approval Date
CN (28 Nov 2023),
Diabetes Mellitus, Type 2
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Liraglutide Biosimilar (Tonghua Dongbao)
CTR20190885 / CompletedPhase 1
随机、双盲、单剂量、2x2交叉研究，以证明通化东宝利拉鲁肽注射液和诺和力在健康受试者中生物等效性试验
[Translation] A randomized, double-blind, single-dose, 2x2 crossover study to demonstrate the bioequivalence of Tonghua Dongbao Liraglutide Injection and Victoza in healthy subjects
CTR20190791 / CompletedPhase 3
II期多中心随机开放标签平行组为期26周，比较利拉鲁肽注射液和诺和力在2型糖尿病中的疗效和安全性
[Translation] Phase II multicenter randomized open-label parallel group for 26 weeks to compare the efficacy and safety of liraglutide injection and Victoza in type 2 diabetes
100 Clinical Results associated with Liraglutide Biosimilar (Tonghua Dongbao)
Login to view more data
100 Translational Medicine associated with Liraglutide Biosimilar (Tonghua Dongbao)
Login to view more data
100 Patents (Medical) associated with Liraglutide Biosimilar (Tonghua Dongbao)
Login to view more data
100 Deals associated with Liraglutide Biosimilar (Tonghua Dongbao)
Login to view more data

External Link

KEGGWikiATCDrug Bank
D06404--
DB06655

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2
CN
Tonghua Dongbao Pharmaceutical Co., Ltd.Tonghua Dongbao Pharmaceutical Co., Ltd.
28 Nov 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free